Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Radiotherapy for breast cancer often involves some incidental exposure of the heart to ionizing radiation. The effect of this exposure on the subsequent risk of ischemic heart disease is uncertain. METHODS: We conducted a population-based case-control study of major coronary events (i.e., myocardial infarction, coronary revascularization, or death from ischemic heart disease) in 2168 women who underwent radiotherapy for breast cancer between 1958 and 2001 in Sweden and Denmark; the study included 963 women with major coronary events and 1205 controls. Individual patient information was obtained from hospital records. For each woman, the mean radiation doses to the whole heart and to the left anterior descending coronary artery were estimated from her radiotherapy chart. RESULTS: The overall average of the mean doses to the whole heart was 4.9 Gy (range, 0.03 to 27.72). Rates of major coronary events increased linearly with the mean dose to the heart by 7.4% per gray (95% confidence interval, 2.9 to 14.5; P<0.001), with no apparent threshold. The increase started within the first 5 years after radiotherapy and continued into the third decade after radiotherapy. The proportional increase in the rate of major coronary events per gray was similar in women with and women without cardiac risk factors at the time of radiotherapy. CONCLUSIONS: Exposure of the heart to ionizing radiation during radiotherapy for breast cancer increases the subsequent rate of ischemic heart disease. The increase is proportional to the mean dose to the heart, begins within a few years after exposure, and continues for at least 20 years. Women with preexisting cardiac risk factors have greater absolute increases in risk from radiotherapy than other women. (Funded by Cancer Research UK and others.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recent evidence shows risk at lower doses (<0.5 Gy), with an estimated latency of 10 years or more29–31.”
From Red risks for a journey to the red planet: The highest priority human health risks for a mission to Mars (2020) · cites this paper as [29]
Citations
Cites
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Applied Regression Analysis and Other Multivariable Methods
Walker, E. (1989) · Technometrics · doi:10.1080/00401706.1989.10488486 · Cited by 8,538
(2011) · The Lancet · doi:10.1016/s0140-6736(11)61629-2 · Cited by 3,937
Self-citationCardiovascular Complications of Cancer Therapy
Yeh, E. T. H., & Bickford, C. L. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.050 · Cited by 1,275
The completeness of the Swedish Cancer Register – a sample survey for year 1998
Barlow, L., Westergren, K., Holmberg, L., & Talbäck, M. (2009) · Acta Oncologica · doi:10.1080/02841860802247664 · Cited by 1,236
Radiation Dose–Volume Effects in the Heart
Gagliardi, G., Constine, L. S., Moiseenko, V., Correa, C., Pierce, L. J., Allen, A. M., & Marks, L. B. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.04.093 · Cited by 1,227
Self-citationDarby, S. C., McGale, P., Taylor, C. W., & Peto, R. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70251-5 · Cited by 1,049
Self-citationLifetime risks of cardiovascular disease
Berry, J. D., Dyer, A., Cai, X., Garside, D. B., Ning, H., Thomas, A., Greenland, P., Van Horn, L., Tracy, R. P., & Lloyd-Jones, D. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1012848 · Cited by 945
Cuzick, J., Stewart, H., Rutqvist, L., Houghton, J., Edwards, R., Redmond, C., Peto, R., Baum, M., Fisher, B., & Host, H. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.3.447 · Cited by 889
Self-citation
Research works printed but not linked: 1
- Jones B, 2001, Clin Oncol (R Coll Radiol), 13, 71
Cited by
Items 501–600 of 1,001
Breast cancer diagnosis and death in the Netherlands: a changing burden
van der Waal, D., Verbeek, A. L. M., den Heeten, G. J., Ripping, T. M., Tjan‐Heijnen, V. C. G., & Broeders, M. J. M. (2014) · European Journal of Public Health · doi:10.1093/eurpub/cku088 · Cited by 53
Pham, T. T., Ward, R., Latty, D., Owen, C., Gebski, V., Chojnowski, J. M., Kelly, C., Ahern, V., Tiver, K. W., Stuart, K. E., et al. (2016) · Journal of Medical Imaging and Radiation Oncology · doi:10.1111/1754-9485.12459 · Cited by 53
TUOHINEN, S. S., Skyttä, T., Poutanen, T., Huhtala, H., Virtanen, V., Kellokumpu‐Lehtinen, P., & Raatikainen, P. M. J. (2016) · International journal of cardiac imaging · doi:10.1007/s10554-016-1021-y · Cited by 56
Survival Impact of Cardiac Dose Following Lung Stereotactic Body Radiotherapy
Wong, O. Y., Yau, V., Kang, J., Glick, D., Lindsay, P. E., Le, L. W., Sun, A. Y., Bezjak, A., Cho, J., Hope, A. J., et al. (2017) · Clinical Lung Cancer · doi:10.1016/j.cllc.2017.08.002 · Cited by 56
Beebe‐Dimmer, J., Ruterbusch, J. J., Harper, F. W. K., Baird, T. E., Finlay, D. G., Rundle, A., Pandolfi, S. S., Hastert, T. A., Schwartz, K., Bepler, G., et al. (2020) · Cancer · doi:10.1002/cncr.32725 · Cited by 55
“Studies have also shown that in comparison with individuals without cancer, breast and prostate cancer survivors actually have a greater risk of developing and dying of cardiovascular disease.(4,8) This excess risk has been partially attributed to the effects of their treatment.”
ResultCorradini, S., Ballhausen, H., Weingandt, H., Freislederer, P., Schönecker, S., Niyazi, M., Simonetto, C., Eidemüller, M., Ganswindt, U., & Belka, C. (2017) · Strahlentherapie und Onkologie · doi:10.1007/s00066-017-1226-6 · Cited by 53
Sadhu, S., Decker, C., Sansbury, B. E., Marinello, M., Seyfried, A. N., Howard, J. E., Mori, M., Hosseini, Z., Arunachalam, T., Finn, A. V., et al. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100284 · Cited by 54
Lee, C., Min, H. D., Befera, N. T., Clark, D. P., Qi, Y. P., Das, S. K., Johnson, G. A., Badea, C. T., & Kirsch, D. G. (2014) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2013.11.238 · Cited by 55
Observational evidence and strength of evidence domains: case examples
O’Neil, M., Berkman, N., Hartling, L., Chang, S., Anderson, J., Motu’apuaka, M., Guise, J.-M., & McDonagh, M. S. (2014) · Systematic Reviews · doi:10.1186/2046-4053-3-35 · Cited by 48
Apnea-like suppression of respiratory motion: First evaluation in radiotherapy
Péguret, N., Özşahin, M., Zeverino, M., Belmondo, B., Durham, A., Lovis, A., Simons, J., Long, O., Duclos, F., Prior, J. O., et al. (2016) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2015.10.011 · Cited by 52
Kabacik, S., & Raj, K. (2017) · Oncotarget · doi:10.18632/oncotarget.18282 · Cited by 52
“The epidemiological data from breast cancer patients shows that the risk of CVD started to increase 5 years after radiotherapy [3], which presents”
BackgroundNationwide Trends in Heart-Sparing Techniques Utilized in Radiation Therapy for Breast Cancer
Desai, N., Currey, A. D., Kelly, T. R., & Bergom, C. R. (2019) · Advances in Radiation Oncology · doi:10.1016/j.adro.2019.01.001 · Cited by 54
Proceedings From the Global Cardio-Oncology Summit
Lenihan, D. J., Fradley, M. G., Dent, S. F., Brezden‐Masley, C., Carver, J. R., Filho, R. K., Neilan, T. G., Blaes, A. H., Melloni, C., Herrmann, J., et al. (2019) · JACC CardioOncology · doi:10.1016/j.jaccao.2019.11.007 · Cited by 56
“The association with long-term coronary disease after chest radiation is well established (83,84).”
BackgroundChang, J. S., Chang, J. H., Kim, N., Kim, Y. B., Shin, K. H., & Kim, K. (2022) · Journal of Breast Cancer · doi:10.4048/jbc.2022.25.e37 · Cited by 56
“Regional nodal irradiation using IMRT A study published in 2013 by Darby et al. showed a linear no-threshold relationship between mean heart dose (MHD) and the incidence of heart disease after breast RT, finding a 7.4% relative risk of ischemic heart disease for every 1-Gy increment in MHD [52].”
BackgroundInfluentialLutz, C. M., Poulsen, P. R., Fledelius, W., Offersen, B. V., & Thomsen, M. S. (2015) · Acta Oncologica · doi:10.3109/0284186x.2015.1045625 · Cited by 54
A new split arc VMAT technique for lymph node positive breast cancer
Boman, E. L., Rossi, M. E., Haltamo, M., Skyttä, T., & Kapanen, M. K. (2016) · Physica Medica · doi:10.1016/j.ejmp.2016.10.012 · Cited by 51
Stick, L. B., Yu, J., Maraldo, M. V., Aznar, M. C., Pedersen, A. N., Bentzen, S. M., & Vogelius, I. R. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2016.12.008 · Cited by 51
“Table S13 in the appendix of the article by Darby et al (4) contains excess absolute risk (EAR) estimates of at least 1 acute coronary event (ACE) at age 80 years, where an ACE was defined as myocardial infarction, coronary revascularization, angina, or death from ischemic heart disease.”
BackgroundMethodInfluentialAssessment and management of radiotherapy induced toxicity in older patients
O’Donovan, A., Leech, M., & Gillham, C. (2017) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2017.07.001 · Cited by 51
Common Cardiovascular Complications of Cancer Therapy: Epidemiology, Risk Prediction, and Prevention
Narayan, V., & Ky, B. (2018) · Annual Review of Medicine · doi:10.1146/annurev-med-041316-090622 · Cited by 52
Finnegan, R., Dowling, J., Koh, E., Tang, S., Otton, J. M., Delaney, G. P., Batumalai, V., Luo, C., Atluri, P., Satchithanandha, A., et al. (2019) · Physics in Medicine and Biology · doi:10.1088/1361-6560/ab0ea6 · Cited by 52
“…is associated with increased mortality from cardiovascular disease and lung cancer after 10–20 years (Darby et al 2005, Hooning et al 2007), with Darby et al (2013) quantifying the increased risk of cardiac events due to mean radiation dose to the whole heart during treatment for left sided…”
BackgroundOechsner, M., Düsberg, M., Borm, K. J., Combs, S. E., Wilkens, J. J., & Duma, M. N. (2019) · Radiation Oncology · doi:10.1186/s13014-019-1293-1 · Cited by 51
Smith, N. L., Jethwa, K. R., Viehman, J. K., Harmsen, W. S., Gonuguntla, K., Elswick, S. M., Grauberger, J. N., Amundson, A. C., Whitaker, T. J., Remmes, N. B., et al. (2019) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2019.05.022 · Cited by 51
“events has previously been observed, and since validated in large population-based studies [19,47].”
BackgroundHeart Failure After Treatment for Breast Cancer
Boekel, N. B., Duane, F. K., Jacobse, J. N., Hauptmann, M., Schaapveld, M., Sonke, G. S., Gietema, J. A., Hooning, M. J., Seynaeve, C., Maas, A. H. E. M., et al. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1620 · Cited by 51
Self-citationSubramanian, V., Seemann, I., Merl‐Pham, J., Hauck, S. M., Stewart, F., Atkinson, M. J., Tapio, S., & Azimzadeh, O. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00795 · Cited by 53
New Insights into the Understanding of Mechanisms of Radiation-Induced Heart Disease
Wang, K., Ye, C., Xu, Y., Ma, P., Chen, Y., & Luo, L. (2023) · Current Treatment Options in Oncology · doi:10.1007/s11864-022-01041-4 · Cited by 53
“mum dose threshold below which would not damage the heart [6].”
BackgroundIncreased risk of death due to heart disease after radiotherapy for esophageal cancer.
Frandsen, J. E., Boothe, D. L., Gaffney, D. K., Wilson, B. D., & Lloyd, S. A. J. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2078-6891.2015.040 · Cited by 64
“3% increased relative risk for major coronary event from 0-4 years after RT for breast cancer (23).”
BackgroundSmoking Cessation Reverses DNA Double-Strand Breaks in Human Mononuclear Cells
Ishida, M., Ishida, T., Tashiro, S., Uchida, H., Sakai, C., Hironobe, N., Miura, K., Hashimoto, Y., Arihiro, K., Chayama, K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103993 · Cited by 52
“Second, exposure of the heart to ionizing radiation during radiotherapy for breast cancer increases the risk of coronary artery disease [6].”
BackgroundValente, S. A., Tendulkar, R. D., Cherian, S., O’Rourke, C., Greif, J. M., Bailey, L., Uhl, V., Bethke, K. P., Donnelly, E. D., Rudolph, R., et al. (2016) · Annals of Surgical Oncology · doi:10.1245/s10434-016-5240-1 · Cited by 52
Muhsen, S., Moo, T.-A. S., Patil, S. N., Stempel, M. M., Powell, S. N., Morrow, M., & El-Tamer, M. B. (2018) · Annals of Surgical Oncology · doi:10.1245/s10434-018-6422-9 · Cited by 50
Cancer and Coronary Artery Disease: Common Associations, Diagnosis and Management Challenges
Das, D. K., Asher, A., & Ghosh, A. K. (2019) · Current Treatment Options in Oncology · doi:10.1007/s11864-019-0644-3 · Cited by 50
Ward, M. C., Vicini, F. A., Chadha, M., Pierce, L. J., Recht, A., Hayman, J. A., Thaker, N. G., Khan, A. J., Keisch, M. E., & Shah, C. (2019) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2019.06.014 · Cited by 51
Cardiovascular diseases in survivors of childhood cancer
Bansal, N., Blanco, J. G., Sharma, U. C., Pokharel, S., Shisler, S., & Lipshultz, S. E. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09859-w · Cited by 51
“4% increase per Gy in breast cancer patients who received tangential fractionated irradiation [77], a 33% increase per Gy in lung cancer patients treated with radiotherapy [78], and an increase of 1.”
BackgroundCardiovascular Damage Associated With Chest Irradiation
Mrotzek, S. M., Rassaf, T., & Totzeck, M. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00041 · Cited by 57
“In women who underwent radiotherapy for breast cancer an increase of major coronary events started within the first 5 years after radiotherapy and continued into the third decade after radiotherapy (26).”
BackgroundCardiovascular disease-specific mortality in 270,618 patients with non-small cell lung cancer
Sun, J., Zhang, Z., Qu, Q., Wang, N., Zhang, Y., Miao, L.-F., Ji, W., Wu, L., Liu, Y., Zhang, C.-Y., et al. (2021) · International Journal of Cardiology · doi:10.1016/j.ijcard.2021.02.025 · Cited by 55
Radiation-induced lung damage promotes breast cancer lung-metastasis through CXCR4 signaling
Feys, L., Descamps, B., Vanhove, C., Vral, A., Veldeman, L., Vermeulen, S. J. T., Wagter, C. D., Bracke, M., & Wever, O. D. (2015) · Oncotarget · doi:10.18632/oncotarget.5666 · Cited by 52
“Incidental cardiopulmonary irradiation is clinically important since it increases the subsequent rate of ischemic heart disease and secondary lung cancer risk [9, 10].”
BackgroundMethodVasu, S., & Hundley, W. G. (2013) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-15-66 · Cited by 51
“Several therapeutic interventions including the administration of chemotherapy [15], immunotherapy [16], hormone deprivation [17] and radiation related therapy [18,19] have been associated with CV related increases in morbidity or mortality.”
BackgroundRegister, S. P., Takita, C., dos Reis, I. M., Zhao, W. K., Amestoy, W., & Wright, J. L. (2014) · Medical dosimetry · doi:10.1016/j.meddos.2014.10.005 · Cited by 52
“Numerous randomized trials and meta-analyses have shown its effectiveness in improving locoregional control and survival in both the breast-conserving (BCT) and postmastectomy settings.1-5 Despite these benefits, the 2005 update of the Early Breast Cancer Trialists' Collaborative Group meta-analysis showed increased r…”
BackgroundInfluentialRutter, C. E., Chagpar, A. B., & Evans, S. B. (2014) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.06.030 · Cited by 51
Cucinotta, F. A., Hamada, N., & Little, M. P. (2016) · Life Sciences in Space Research · doi:10.1016/j.lssr.2016.08.002 · Cited by 57
McCullough, M. L., Gapstur, S. M., Shah, R. A., Campbell, P. T., Wang, Y., Doyle, C., & Gaudet, M. M. (2016) · Cancer Causes & Control · doi:10.1007/s10552-016-0802-x · Cited by 53
“Given the growing recognition that healthy dietary patterns are associated with lower chronic disease risk [18], and some breast cancer therapies increase risk of ischemic heart disease [19], understanding the role of dietary patterns and survival in breast cancer patients has important health implications for this gr…”
Guberina, M., Eberhardt, W., Stuschke, M., Gauler, T. C., Heinzelmann, F., Cheufou, D. H., Kimmich, M., Friedel, G., Schmidberger, H., Darwiche, K., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx069 · Cited by 49
Rygiel, K. (2017) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.187303 · Cited by 57
Cardiotoxicity of cancer chemotherapy: identification, prevention and treatment
Jain, D., Ahmad, T., Cairo, M. S., & Aronow, W. S. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.06.35 · Cited by 49
“A significant increase in the incidence for cardiovascular disease has been observed in long-term cancer survivors exposed to radiation therapy, including increased need for CABG and coronary interventions (52-54).”
BackgroundRetractedCheng, S. H., Huang, T., Cheng, Y., Tan, B. K. T., Horng, C.-F., Wang, Y. A., Shannon, N. B., Shih, L., & Yu, B.-L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184372 · Cited by 53
Stam, B., van der Bijl, E., van Diessen, J., Rossi, M. M. G., Tijhuis, A., Belderbos, J. S. A., Damen, E. M. F., & Sonke, J. (2017) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2017.09.004 · Cited by 49
“An increased risk of heart disease decades after thoracic radiotherapy is well established in breast cancer and Hodgkin lymphoma patients [1,2].”
BackgroundBerg, M., Lorenzen, E. L., Jensen, I., Thomsen, M. S., Lutz, C. M., Refsgaard, L. H., Nissen, H. D., & Offersen, B. V. (2017) · Acta Oncologica · doi:10.1080/0284186x.2017.1406139 · Cited by 50
“On the other hand, adjuvant RT also increases the risk of heart- and lung-related toxicity compared to women not receiving RT [4,5].”
BackgroundLiang, X., Bradley, J. A., Zheng, D., Rutenberg, M. S., Yeung, D. K., Mendenhall, N. P., & Li, Z. (2018) · Radiation Oncology · doi:10.1186/s13014-018-1004-3 · Cited by 49
“Despite survival gains, radiation is associated with an increased risk of heart and lung disease (REF) [3, 4].”
BackgroundAbdominal DIBH reduces the cardiac dose even further: a prospective analysis
Zhao, F., Shen, J., Lu, Z., Luo, Y., Yao, G., Bu, L., Ge, J., Yang, X. Y., Ning, L., & Yan, S. (2018) · Radiation Oncology · doi:10.1186/s13014-018-1062-6 · Cited by 50
Effects of Radiotherapy in Coronary Artery Disease
da Silva, R. M. F. L. (2019) · Current Atherosclerosis Reports · doi:10.1007/s11883-019-0810-x · Cited by 60
Tromp, J., Boerman, L. M., Sama, I. E., Maass, S. W. M. C., Maduro, J. H., Hummel, Y. M., Berger, M. Y., de Bock, G. H., Gietema, J. A., Berendsen, A. J., et al. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1758 · Cited by 50
Mulrooney, D. A., Nunnery, S. E., Armstrong, G. T., Ness, K. K., Srivastava, D. K., Donovan, F., Kurt, B. A., Metzger, M. L., Krasin, M. J., Joshi, V. M., et al. (2014) · Cancer · doi:10.1002/cncr.28925 · Cited by 48
“4% increase in coronary events per Gy of radiation to the heart.(26) Progression and the long-term outcome of this subclinical disease may not yet be evident.”
BackgroundPotential Radiation-Related Effects on Radiologists
Parikh, J. R., Geise, R. A., Bluth, E. I., Bender, C. E., Sze, G. K., & Jones, A. K. (2016) · American Journal of Roentgenology · doi:10.2214/ajr.16.17212 · Cited by 55
Tommasino, F., Durante, M., D’Avino, V., Liuzzi, R., Conson, M., Farace, P., Palma, G., Schwarz, M., Cella, L., & Pacelli, R. (2017) · Acta Oncologica · doi:10.1080/0284186x.2017.1299218 · Cited by 48
“…LKB model: TD50¼ 29 Gy, m¼ 0.41, n¼ 0.16 LAD Coronary stenosis Moignier et al. (2015) [18] Logistic model: (OR)^Dmed OR¼ 1.049 Heart Major coronary events Darby et al. (2013) [6] Linear model: Bs (1þ KD) D dose in Gy, K¼ 0.074/Gy Left lung Radiation fibrosis Cella et al. (2015) [7] Logistic…”
BackgroundInfluentialBaselet, B., Belmans, N., Coninx, E., Lowe, D., Janssen, A., Michaux, A., Tabury, K., Raj, K., Quintens, R., Benotmane, M. A., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00213 · Cited by 54
“At higher doses of ionizing radiation ( > 0.5 Gy), epidemiological data show a significant excess risk of late occurring cardiovascular disease (CVD; Hildebrandt, 2010; Shimizu et al., 2010; Darby et al., 2013).”
InfluentialNowsheen, S., Viscuse, P. V., O'Sullivan, C. C., Sandhu, N. P., Haddad, T. C., Blaes, A. H., Klemp, J. R., Nhola, L. F., Herrmann, J., & Ruddy, K. J. (2017) · Current Breast Cancer Reports · doi:10.1007/s12609-017-0249-4 · Cited by 48
“ischemic heart disease, especially in women with preexisting cardiac risk factors [3].”
Kim, A., Kalet, A. M., Cao, N., Hippe, D. S., Fang, L. C., Young, L., Meyer, J., Lang, E. V., & Mayr, N. A. (2018) · Clinical Oncology · doi:10.1016/j.clon.2018.04.009 · Cited by 49
Cardiotoxicity of Radiation Therapy: Mechanisms, Management, and Mitigation
Ell, P., Martin, J. M., Cehic, D., Ngo, D. T. M., & Sverdlov, A. L. (2021) · Current Treatment Options in Oncology · doi:10.1007/s11864-021-00868-7 · Cited by 48
Fang, F., Bhoo‐Pathy, N., Brand, J. S., Hedayati, E., Grassmann, F., Zeng, E., Bergh, J. C. S., Bian, W., Ludvigsson, J. F., Hall, P., et al. (2022) · eLife · doi:10.7554/elife.71562 · Cited by 50
Self-citationCardiovascular disease risk in long‐term breast cancer survivors: A population‐based cohort study
Koric, A., Chang, C.-P. E., Mark, B., Rowe, K. G., Snyder, J., Dodson, M. W., Deshmukh, V. G., Newman, M. G., Fraser, A. M., Smith, K. R., et al. (2022) · Cancer · doi:10.1002/cncr.34224 · Cited by 48
“In a study of 2535 breast cancer patients, most of whom were identified in the Cancer Genetics Network, Hill et al observed no increased risk for heart disease for >10 years after cancer diagnosis compared with the general population.(8,11) A possible explanation for the difference in risk estimations from the Schoorm…”
BackgroundResultWalls, G., McCann, C. J., O’Connor, J. D., O'Sullivan, A., Johnston, D. I., McAleese, J., McGarry, C. K., Cole, A., Jain, S., Butterworth, K. T., et al. (2024) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2024.110085 · Cited by 50
Ten-Year Survival after Postmastectomy Chest-Wall Irradiation in Breast Cancer
Kunkler, I. H., Russell, N. S., Anderson, N., Sainsbury, R., Dixon, J. M., Cameron, D., Loncaster, J. A., Hatton, M. Q. F., Westenberg, H., Clarke, J., et al. (2025) · New England Journal of Medicine · doi:10.1056/nejmoa2412225 · Cited by 47
Damkjær, S. M. S., Aznar, M. C., Pedersen, A. N., Vogelius, I. R., Bangsgaard, J. P., & Josipović, M. (2013) · Acta Oncologica · doi:10.3109/0284186x.2013.813073 · Cited by 47
Boerman, L. M., Maass, S. W. M. C., van der Meer, P., Gietema, J. A., Maduro, J. H., Hummel, Y. M., Berger, M. Y., de Bock, G. H., & Berendsen, A. J. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.05.013 · Cited by 50
“An increased incidence of ischaemic heart disease is generally expected among patients treated by radiotherapy only [41].”
BackgroundLaw, W., Johnson, C. B., Rushton, M. K., & Dent, S. F. (2017) · Current Oncology · doi:10.3747/co.24.3684 · Cited by 47
Cardiovascular complications after radiotherapy
Nabiałek-Trojanowska, I., Lewicka, E., Wrona, A., Kaleta, A. M., Lewicka-Potocka, Z., Raczak, G., & Dziadziuszko, R. (2018) · Cardiology Journal · doi:10.5603/cj.a2018.0120 · Cited by 51
“Hodgkin lymphoma and early-stage breast cancer [8, 9].”
Postmastectomy radiotherapy for left-sided breast cancer patients: Comparison of advanced techniques
Xie, Y., Bourgeois, D. J., Guo, B., & Zhang, R. (2019) · Medical dosimetry · doi:10.1016/j.meddos.2019.04.005 · Cited by 49
Dosimetric Predictors of Cardiotoxicity in Thoracic Radiotherapy for Lung Cancer
Borkenhagen, J. F., Bergom, C. R., Rapp, C. T., Klawikowski, S., Rein, L., & Gore, E. (2019) · Clinical Lung Cancer · doi:10.1016/j.cllc.2019.05.014 · Cited by 47
Yaney, A., Ayan, A. S., Pan, X. J., Jhawar, S. R., Healy, E. H., Beyer, S. J., Lindsey, K., Kuhn, K., Tedrick, K., White, J. R., et al. (2020) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2020.10.042 · Cited by 47
Loap, P., Tkatchenko, N., Goudjil, F., Ribeiro, M., Baron, B., Fourquet, A., & Kirova, Y. (2021) · Acta Oncologica · doi:10.1080/0284186x.2021.1907860 · Cited by 47
“However, first generation techniques, which relied on large irradiation fields, were associated with a significantly increased cardiac-related toxicity and mortality [3].”
BackgroundEvaluation of deep learning-based autosegmentation in breast cancer radiotherapy
Byun, H. K., Chang, J. S., Choi, M. S., Chun, J., Jung, J., Jeong, C., Kim, J. S., Chang, Y., Chung, S. Y., Lee, S.-R., et al. (2021) · Radiation Oncology · doi:10.1186/s13014-021-01923-1 · Cited by 49
Artificial intelligence based treatment planning of radiotherapy for locally advanced breast cancer
van de Sande, D., Sharabiani, M., Bluemink, H., Kneepkens, E., Bakx, N., Hagelaar, E., van der Sangen, M., Theuws, J. C. M., & Hurkmans, C. (2021) · Physics and Imaging in Radiation Oncology · doi:10.1016/j.phro.2021.11.007 · Cited by 47
“4% per Gy on the mean heart dose [20], while Taylor et al.”
BackgroundComparison of breast simultaneous integrated boost (SIB) radiotherapy techniques
Aly, M. M. O. M., Glatting, G., Jahnke, L., Wenz, F. K., & Abo‐Madyan, Y. (2015) · Radiation Oncology · doi:10.1186/s13014-015-0452-2 · Cited by 47
“4 % per 1 Gy increase in the mean radiation dose delivered to the heart [34].”
BackgroundEffect of Oxidative Stress on Cardiovascular System in Response to Gravity
Takahashi, K., Okumura, H., Guo, R., & Naruse, K. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071426 · Cited by 46
“In the cardiovascular system, radiation causes ischemic heart disease [50], cardiomyopathy, and stroke [51,52].”
BackgroundKorzets, Y., Fyles, A., Shepshelovich, D., Amir, E., & Goldvaser, H. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-019-05209-9 · Cited by 48
Pan-Cancer Analysis of Postdiagnosis Exercise and Mortality
Lavery, J. A., Boutros, P. C., Scott, J. M., Tammela, T., Moskowitz, C. S., & Jones, L. W. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.23.00058 · Cited by 48
Predicting Adverse Cardiac Events After Radiotherapy for Locally Advanced Non–Small Cell Lung Cancer
No, H. J., Guo, F. B., Park, N., Kastelowitz, N., Rhee, J., Clark, D. E., Chin, A. L.-C., Vitzthum, L. K., Horst, K. C., Moding, E. J., et al. (2023) · JACC CardioOncology · doi:10.1016/j.jaccao.2023.08.007 · Cited by 51
Goldstein, J. D., Lawrence, Y. R., Appel, S., Landau, E., Ben-David, M. A., Rabin, T., Ben-Ayun, M., Dubinski, S., Weizman, N., Alezra, D., et al. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.06.011 · Cited by 50
Lin, A., Sharieff, W., Juhasz, J., Whelan, T. J., & Kim, D. (2016) · Breast Cancer · doi:10.1007/s12282-016-0676-5 · Cited by 47
FLASH radiotherapy: Newsflash or flash in the pan?
Maxim, P. G., Keall, P., & Cai, J. (2019) · Medical Physics · doi:10.1002/mp.13685 · Cited by 48
Yamauchi, R., Mizuno, N., Itazawa, T., Saitoh, H., & Kawamori, J. (2020) · Journal of Radiation Research · doi:10.1093/jrr/rraa006 · Cited by 46
Sears, J. J., Swanner, J. L., Fahrenholtz, C. D., Snyder, C. M., Rohde, M. M., Levi‐Polyachenko, N. H., & Singh, R. N. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s296513 · Cited by 47
Beck, R. E., Kim, L. H., Yue, N. J., Haffty, B. G., Khan, A. J., & Goyal, S. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00327 · Cited by 45
“Mean heart dose is also used as a common reference dose constraint given reports of clinical outcomes in studies using this parameter (8).”
MethodBenefit of low‐dose tamoxifen in a large observational cohort of high risk ER positive breast DCIS
Guerrieri‐Gonzaga, A., Šestak, I., Lazzeroni, M., Serrano, D., Rotmensz, N., Cazzaniga, M., Varricchio, C., Pruneri, G., Leonardi, M. C., Orecchia, R., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.30254 · Cited by 46
Rushton, M. K., Johnson, C. B., & Dent, S. F. (2017) · Current Oncology · doi:10.3747/co.24.3349 · Cited by 47
“Discontinued because of cardiac event 11 (9) 3 (21) 3 (30)”
BackgroundWink, K. C. J., Roelofs, E., Simone, C. B., Dechambre, D., Santiago, A., van der Stoep, J., Dries, W., Smits, J., Avery, S., Ammazzalorso, F., et al. (2018) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2018.02.024 · Cited by 47
Cardiotoxicity of mediastinal radiotherapy
Ratoša, I., & Pantar, M. I. (2019) · Reports of Practical Oncology & Radiotherapy · doi:10.1016/j.rpor.2019.09.002 · Cited by 45
Connexin43 Hemichannel Targeting With TAT-Gap19 Alleviates Radiation-Induced Endothelial Cell Damage
Ramadan, R., Vromans, E., Anang, D. C., Goetschalckx, I., Hoorelbeke, D., Decrock, E., Baatout, S., Leybaert, L., & Aerts, A. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00212 · Cited by 47
Guang, Y., He, W., Zhang, W., Zhang, H., Zhang, Y., & Wan, F. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.791970 · Cited by 45
“When central lymph node metastasis (CLNM) is found in patients after surgery, a second operation is often necessary, increasing not only the difficulty of surgery but also the risk of complications such as recurrent laryngeal nerve injury and reduced parathyroid function; moreover, CLNM is an important risk factor for…”
BackgroundMeattini, I., GUENZI, M., Fozza, A., Vidali, C., Rovea, P., Meacci, F., & Livi, L. (2016) · Breast Cancer · doi:10.1007/s12282-016-0694-3 · Cited by 56
Deep inspiration breath hold reduces the mean heart dose in left breast cancer radiotherapy
Falco, M., Masojć, B., Macała, A., Łukowiak, M., Woźniak, P., & Malicki, J. (2021) · Radiology and Oncology · doi:10.2478/raon-2021-0008 · Cited by 45
Boersma, L. J., Sattler, M. G. A., Maduro, J. H., Bijker, N., Essers, M., van Gestel, C. M. J., Klaver, Y. L. B., Petoukhova, A., Rodrigues, M. F., Russell, N. S., et al. (2022) · Clinical Oncology · doi:10.1016/j.clon.2021.12.007 · Cited by 47
Lee, J., Hua, K., Hsu, S., Lin, J., Lee, C.-H., Lu, K.-W., Dai, K.-Y., Huang, X.-N., Huang, J.-Z., Wu, M., et al. (2017) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2016.12.029 · Cited by 49
Cardio-oncology in the older adult
Reddy, P., Shenoy, C., & Blaes, A. H. (2017) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2017.04.001 · Cited by 44
“Not surprisingly, there was also an increase in major coronary events in older patients especially those with pre-existing cardiac risk (48).”
BackgroundHong, J. C., Rahimy, E., Gross, C. P., Shafman, T. D., Hu, X. Y., Yu, J. B., Ross, R., Finkelstein, S. E., Dosoretz, A. P., Park, H. S.-M., et al. (2017) · Practical Radiation Oncology · doi:10.1016/j.prro.2017.07.005 · Cited by 45
Impact of Ionizing Radiation on the Cardiovascular System: A Review
Puukila, S., Lemon, J. A., Lees, S. J., Tai, T. C., Boreham, D. R., & Khaper, N. (2017) · Radiation Research · doi:10.1667/rr14864.1 · Cited by 44
Cardiovascular phenotype and prognosis of patients with heart failure induced by cancer therapy
Nadruz, W., West, E., Sengeløv, M., Grove, G. L., Santos, M., Groarke, J. D., Forman, D. E., Claggett, B. L., Skali, H., Nohria, A., et al. (2018) · Heart · doi:10.1136/heartjnl-2018-313234 · Cited by 44
Xiao, A., Crosby, J., Malin, M. J., Kang, H., Washington, M., Hasan, Y., Chmura, S. J., & Al‐Hallaq, H. (2018) · Journal of Applied Clinical Medical Physics · doi:10.1002/acm2.12368 · Cited by 44
“However, collateral toxicities to the heart and lungs remain a significant challenge.(3,4) Deep-inspiration breath-hold (DIBH) harnesses the advantage of organ motion during the respiratory cycle to minimize overlap of the heart and lungs with the treatment fields.”
BackgroundMorris, E. D., Ghanem, A. I., Pantelic, M., Walker, E., Han, X., & Glide‐Hurst, C. K. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2018.11.025 · Cited by 47
“Moreover, major coronary events have been linked to radiation dose to the heart with a ~7%/Gy increase in rate of ischemic heart disease[4].”
BackgroundArterial events in cancer patients—the case of acute coronary thrombosis
Oren, O., & Herrmann, J. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.12.79 · Cited by 46
“Indeed, coronary artery disease can emerge in not an insubstantial number of breast cancer patients (74-76), as well as Hodgkin lymphoma patients (77).”
BackgroundDell’Oro, M., Giles, E., Sharkey, A. R., Borg, M. F., Connell, C., & Bezak, E. (2019) · Cancers · doi:10.3390/cancers11020259 · Cited by 44
“The maximum heart distance (MHD) is measured on the CT slice with the thickest section of heart contained within the field and is defined as the distance between the anterior cardiac contour crossing over the posterior edge of the tangential fields (Figure 2) [1].”
Background
Metadata
- Authors
- Darby, S. C., Ewertz, M., McGale, P., Bennet, A. M., Blom-Goldman, U., Brønnum, D., Correa, C., Cutter, D., Gagliardi, G., Gigante, B., Jensen, M.-B., Nisbet, A., Peto, R., Rahimi, K., Taylor, C., & Hall, P.
- Affiliations
- University of Oxford (GB)
- University of Southern Denmark (DK)
- Karolinska Institutet (SE)
- Karolinska University Hospital (SE)
- Aalborg University Hospital (DK)
- University of South Florida (US)
- Danderyds sjukhus (SE)
- Rigshospitalet (DK)
- Royal Surrey County Hospital (GB)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2013-03-14
- Volume
- 368
- Issue
- 11
- Pages
- 987-998
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2154375587
- Cited by
- 3,974
- References
- 38
- Citations by year
- 2026: 277 · 2025: 290 · 2024: 270 · 2023: 358 · 2022: 359 · 2021: 392 · 2020: 344 · 2019: 285 · 2018: 278 · 2017: 268 · 2016: 285 · 2015: 259 · 2014: 195 · 2013: 107
- FWCI
- 191.87
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Surrey Research Insight Open Access (The University of Surrey) (submittedVersion)
- VBN Forskningsportal (Aalborg Universitet) (submittedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Funders
- NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research
- Cancer Research UK
- National Institute for Health and Care Research (RRX 108)
- British Heart Foundation (RE/08/004, CRE RE/08/004)
- University of Oxford (RE/08/004)
- European Commission
- Medical Research Council
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Chemotherapy-induced cardiotoxicity and mitigation
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
- Physical Sciences › Physics and Astronomy › Radiation › Advanced Radiotherapy Techniques
- Keywords
- breast cancer radiotherapy, ischemic heart disease, coronary events, myocardial infarction, coronary revascularization, radiation-induced heart disease, left anterior descending artery, radiation dose, cardiovascular risk factors, women
- MeSH terms
- Adult, Aged, Breast Neoplasms, Female, Heart, Humans, Mastectomy, Middle Aged, Radiation Injuries, Radiotherapy Dosage, Risk, Risk Factors, Case-Control Studies, Chemotherapy, Adjuvant, Myocardial Ischemia, Radiotherapy, Adjuvant
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.